Results 171 to 180 of about 22,309 (312)
Study on wind resistance performance of high-rise corridor building based on quasi-steady static aeroelastic analysis method. [PDF]
Zhang Y.
europepmc +1 more source
Knowledge-Based Lift and Drag Coefficient Prediction of Airfoil: A Meta-Learning Structure [PDF]
H Zhang, Yiming Du
openalex +1 more source
The Association of Amyloid‐β and Tau With Synaptic Dysfunction in Alzheimer's Disease
ABSTRACT Objective To clarify the relative contributions of amyloid and tau to synaptic dysfunction in Alzheimer's disease (AD). Methods We included 109 cognitively unimpaired and impaired individuals from the Geneva Memory Center with available CSF synaptic biomarkers (neurogranin, SNAP‐25, GAP‐43). Participants were stratified according to amyloid (A)
Fausto Roveta +11 more
wiley +1 more source
Study on the Optimization of Laser Cladding Process Parameters and Overlap Strategies for CuCrZr Copper Alloy Powders. [PDF]
Yu J, Le DA, Zhang C, Zhao J.
europepmc +1 more source
ABSTRACT Objective Sleep disturbances have been implicated as a risk factor for developing Alzheimer's disease (AD), but evidence linking plasma AD biomarkers to sleep in cognitively unimpaired individuals remains limited. The present study examined associations between evening, morning, and overnight changes in plasma AD biomarkers and measures of ...
Cornelia Sauter +5 more
wiley +1 more source
Parametric Optimization of a Star-Shaped Bluff Body for Enhanced VIV-Galloping Coupled Energy Harvesting. [PDF]
Zhang L, Wang H, Yang C, Duan W, Peng J.
europepmc +1 more source
Two-phase Air Lift Reactor systems: Newtonian and Non-Newtonian Mass transfer coefficient
Naren PR, Vasudha Jeeth Ramkumar
openalex +1 more source
Effect of Angle of Attack on Drag and Lift Coefficients on Naca Airfoil for Wind Turbine Application [PDF]
Priyo Heru Adiwibowo +3 more
openalex +1 more source
ABSTRACT Background Blood‐based biomarkers are increasingly used to identify Alzheimer's disease (AD) pathology and may play an important role in early disease screening and participant selection for clinical trials. However, their performance across stages of cognitive impairment remains unclear. This study examined whether plasma biomarkers differ in
Maryam Abdolmaleki +7 more
wiley +1 more source

